Endogenous SPAS-1 neoantigen-specific CD8+ T cells were increased in number and enriched in tumors following TRAMP-C2 tumor cell were attack and generated CD8+ TRM cells in different tissues (68). This evidence concerns the gene CD8A and neoplasm.